EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improved Broad Spectrum Antifungal Drug Synergies with Cryptomycin, a Cdc50-Inspired Antifungal Peptide

Robert J Tancer, Siddhi Pawar, Yina Wang, Cristina R Ventura, Gregory Wiedman iD, Chaoyang Xue

ACS Infectious Diseases · 2024

DOI: 10.1021/acsinfecdis.4c00681 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2024. Verfasst von Robert J Tancer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Public Health Research Institute and Department of Microbiology, Biochemistry, and Molecular Genetics, New Jersey Medical School, Rutgers University,…. Hauptthemen laut MEDLINE: Antifungal Agents, Microbial Sensitivity Tests, Cryptococcus neoformans, Drug Synergism. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsMicrobial Sensitivity TestsCryptococcus neoformansDrug SynergismFungal ProteinsCandidaAnimalsAspergillus fumigatusHumansDrug Resistance, FungalMicePhospholipid Transfer ProteinsPeptidesReactive Oxygen SpeciesCandida albicans

Stichwörter der Autor:innen

antifungal peptidecdc50drug resistancelipid flippasepathogenic fungi

Substanzen

Antifungal AgentsFungal ProteinsPhospholipid Transfer ProteinsPeptidesReactive Oxygen Species

Autor:innen und Institutionen

  • Public Health Research Institute and Department of Microbiology, Biochemistry, and Molecular Genetics, New Jersey Medical School, Rutgers University, Newark, New Jersey 07103, United States.
  • Department of Chemistry and Biochemistry, Seton Hall University, South Orange, New Jersey 07079, United States.

ORCID-Profile: Gregory Wiedman

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Science Foundation

Zitieren

APA

Tancer, R. J., Pawar, S., Wang, Y., Ventura, C. R., Wiedman, G., & Xue, C. (2024). Improved Broad Spectrum Antifungal Drug Synergies with Cryptomycin, a Cdc50-Inspired Antifungal Peptide. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c00681

Vancouver

Tancer RJ, Pawar S, Wang Y, Ventura CR, Wiedman G, Xue C. Improved Broad Spectrum Antifungal Drug Synergies with Cryptomycin, a Cdc50-Inspired Antifungal Peptide. ACS Infectious Diseases. 2024. doi:10.1021/acsinfecdis.4c00681

BibTeX
@article{Tancer2024,
  author = {Tancer, Robert J and Pawar, Siddhi and Wang, Yina and Ventura, Cristina R and Wiedman, Gregory and Xue, Chaoyang},
  title = {Improved Broad Spectrum Antifungal Drug Synergies with Cryptomycin, a Cdc50-Inspired Antifungal Peptide},
  journal = {ACS Infectious Diseases},
  year = {2024},
  doi = {10.1021/acsinfecdis.4c00681}
}
Kostenlos starten →